Pediatrix Medical Group Announces Board Changes

Ticker: MD · Form: 8-K · Filed: Dec 5, 2024 · CIK: 893949

Pediatrix Medical Group, INC. 8-K Filing Summary
FieldDetail
CompanyPediatrix Medical Group, INC. (MD)
Form Type8-K
Filed DateDec 5, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: board-changes, governance, leadership-transition

TL;DR

Pediatrix board shake-up: Ordan out, Smith & Williams in, Smith is new Chairman.

AI Summary

Pediatrix Medical Group, Inc. announced on November 29, 2024, the departure of director Mark J. Ordan and the appointment of two new directors, David M. Smith and David L. Williams, effective immediately. The company also announced the election of David M. Smith as the new Chairman of the Board. These changes are effective as of November 29, 2024.

Why It Matters

Changes in board leadership and composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing reports routine changes in board membership and leadership, which are common corporate governance events.

Key Players & Entities

FAQ

Who has departed from the Pediatrix Medical Group, Inc. Board of Directors?

Mark J. Ordan has departed from the Board of Directors.

Who are the new directors appointed to the Pediatrix Medical Group, Inc. Board?

David M. Smith and David L. Williams have been appointed as new directors.

What is the effective date of these board changes?

The changes are effective as of November 29, 2024.

Who has been elected as the new Chairman of the Board?

David M. Smith has been elected as the new Chairman of the Board.

What was the previous name of Pediatrix Medical Group, Inc.?

The company was formerly known as MEDNAX, INC. and PEDIATRIX MEDICAL GROUP INC.

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-12-05 16:30:10

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Pediatrix Medical Group, Inc. Date: December 5, 2024 By: /s/ Kasandra H. Rossi Kasandra H. Rossi Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing